Mutations of the HFE gene among Turkish hereditary hemochromatosis patients

Annals of Hematology

Volumn 84, Issue 10, 2005, Pages 646-649

  Simsek, Halis ^a,c   Balaban, Yasemin H ^a   Yilmaz, Engin ^a   Sumer, Hale ^a   Buyukasik, Yahya ^a   Cengiz, Cem ^b   Ozcebe, Osman ^a   Hascelik, Gulsen ^a   Tatar, Gonca ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^c NONE   (Turkey)

Author keywords

H63D mutation; Hereditary hemochromatosis; HFE gene; Sequence analysis

Indexed keywords

HFE PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC DISORDER; GENETIC SCREENING; HEMOCHROMATOSIS; HETEROZYGOSITY; HUMAN; IRON METABOLISM; IRON OVERLOAD; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TURKEY (REPUBLIC);

ADULT; AGED; AMINO ACID SUBSTITUTION; DNA MUTATIONAL ANALYSIS; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POINT MUTATION; TURKEY;

EID: 27644466937     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-005-1048-y     Document Type: Article

References (26)

1. Adams PC (1999) Population screening for hemochromatosis. Hepatology 29:1324-1327
2. Harrison SA, Bacon BR (2005) Relation of hemochromatosis with hepatocellular carcinoma: Epidemiology, natural history, pathophysiology, screening, treatment, and prevention. Med Clin North Am 89:391-409
3. Felitti VJ, Beutler E (1999) New developments in hereditary hemochromatosis. Am J Med Sci 318:257-268
4. Niederau C, Fisher R, Purschel A, Stremmel W, Haussinger D et al (1996) Long-term survival in patients with hereditary hemachromatosis. Gastroenterology 110:1107-1119
5. Hanson EH, Imperatore G, Burke W (2001) HFE gene and hereditary hemochromatosis: A HuGE review. Human genome epidemiology. Am J Epidemiol 154:193-206
6. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399-408
7. The UK Haemochromatosis Consortium (1997) Gut 41:841-844 A simple genetic test identifies 90% of UK patients with haemochromatosis.
8. Camaschella C, Fargion S, Sampietro M, Roetto A, Bosio S et al (1999) Inherited HFE-unrelated hemochromatosis in Italian families. Hepatology 29:1563-1564
9. Aguilar-Martinez P, Bismuth M, Picot MC, Thelcide C, Pageaux GP et al (2001) Variable phenotypic presentation of iron overload in H63D homozygotes: Are genetic modifiers the cause? Gut 48:836-842
10. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJH (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34:275-278
11. Bomford A (2002) Genetics of haemochromatosis. Lancet 360:1673-1681
12. Milman N, A Steig T, Koefoed P, Pedersen P, Fenger K, Nielsen FC (2005) Frequency of the hemochromatosis HFE mutations C282Y, H63D, and S65C in blood donors in the Faroe Islands. Ann Hematol 84:146-149
13. Milman N, Pedersen P, Ovesen L, Melsen GV, Fenger K (2004) Frequency of the C282Y and H63D mutations of the hemochromatosis gene (HFE) in 2501 ethnic Danes. Ann Hematol 83:654-657
14. Bauduer F, Scribans C, Degioanni A, Renoux M, Dutour O (2005) Distribution of the C282Y and H63D polymorphisms in hereditary hemochromatosis patients from the French Basque country. Ann Hematol 84:99-102
15. Simsek H, Sumer H, Yilmaz E, Balaban YH, Ozcebe O, Hascelik G, Buyukask Y, Tatar G (2004) Frequency of HFE mutations among Turkish blood donors according to transferrin saturation. J Clin Gastroenterol 38:671-675
16. El-Serag HB, Inadomi JM, Kowdley KV (2000) Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis. Ann Intern Med 132:261-269
17. Adams PC (2000) Population screening for hemochromatosis. Gut 46:301-303
18. (2000) International consensus conference on hemochromatosis. J Hepatol 33:485-504 EASL
19. Krawczak M, Cooper DN, Schmidtke J (2001) Estimating the efficacy and efficiency of cascade genetic screening. Am J Hum Genet 69:361-370
20. Papanikolaou G, Politou M, Roetto A et al (2001) Linkage to chromosome 1q in Greek families with juvenile hemochromatosis. Blood Cells Mol Dis 27(4):744-749
21. Wallace DF, Pedersen P, Dixon JL et al (2002) Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. Blood 100:692-694
22. Barosia G, Salvaneschi L, Grasso M et al (2002) High prevalence of screening-detected, HFE-unrelated, mild idiopathic iron overload in northern Italy. Haematologica 87(5):472-478
23. Montosi G, Donovan A, Totaro A et al (2001) Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108(4):521-522
24. Piperno A, Arosio C, Fossati L et al (2000) Two novel nonsense mutations of HFE gene in five unrelated Italian patients with hemochromatosis. Gastroenterology 119(2):441-445
25. Pietrangelo A, Montosi G, Totaro A et al (1999) Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene. N Engl J Med 341(10):725-727
26. Njajou OT, Vaessen N, Joosse M et al (2001) A mutation in SCL11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 28:213-214